However, CHAD, whose transcription was not detected at all in RSCCs, was present at notable levels in healthy tissue in LSCCs, while its expression was markedly reduced in tumor tissue and only detectable in about 50% of samples (p < 0.001, Wilcoxon test, Figure 3B). This evidence concerns the gene CHAD and neoplasm.